PATENT CLAIM ANALYSIS

Application Number: 16193762
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "183000"]

Abstract:
The subject invention relates to diffusion enhancing compounds and their use alone or with thrombolytic agents for the treatment of disorders resulting from the formation of a thrombus such as a myocardial infarction or stroke.

Claim (Index 26):
A method as in  claim 22 , wherein when said TSC is subjected to Craw and Lambert analysis the absorbency of the highest peak which occurs in the visible wavelength range divided by the absorbency of the highest peak which occurs in the UV wavelength range is greater than 8.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12801726', '12081236', '13137322', '13067469', '13189413']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7499685861275324
- 35 USC 102 Novelty (BERT): 0.5671993572678201
- Combined Prediction Score: 0.7316916632415612
- Mean Citation Score: 310.9016620000001
- Max Citation Score: 500.5659
- Similarity Product: 306.06330027598136

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test